Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nkechi U. Odukwe
Institution:
Roswell Park Comprehensive Cancer Center
Observed institution:
Roswell Park Comprehensive Cancer Center
ORCID:
0000-0002-7244-4167
Observed ORCID:
0000-0002-7244-4167
OpenAlex ID:
A5094232702
Endogenous CD28 drives CAR T cell responses in multiple myeloma
2024
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
4
PDF
Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
·
Blood Cancer Discovery
·
3
PDF
Supplemental Fig. 5 from Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
Supplemental Fig. 3 from Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
Supplemental Fig. 4 from Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
Supplemental Table 1 from Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
Supplemental Fig. 6 from Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
Supplemental Fig. 2 from Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
Data from Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
Supplemental Fig. 8 from Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
Key Resources Table 1 from Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
Supplemental Gating Strategies 1 from Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
Supplemental Fig. 1 from Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
Supplemental Fig. 7 from Endogenous CD28 Drives the Persistent Activity of CAR T Cells in Myeloma and Lymphoma Models
2026
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
Abstract LB037: CD28 drives CAR T cell responses in multiple myeloma
2025
·
Mackenzie M. Lieberman
, Jason H. Tong
, et al.
·
Cancer Research
Show more works
View as search
Works count:
15
Citation count:
7
H-index:
2
I10-index:
Year
Topic
Type